Tactical Medicine News Blog

REBEL Core Cast 76.0 – Zoom Better

Marco Torres | 9 de marzo de 2022

Andexanet Alfa Vs. Four-Factor PCC: Is Andexanet Alfa Worth The Hype?

Background: Oral factor Xa inhibitors (FXi) have been associated with major and fatal bleeding events, including intracranial hemorrhage (ICH). In randomized controlled trials, both rivaroxaban and apixaban are associated with...

Marco Torres | 28 de febrero de 2022

The ACTION Trial: DOACs in Hospitalized Patients with COVID-19

Background: Patients hospitalized with COVID-19 are at increased risk for both arterial and venous thromboembolic disease. Multiple recent trials have investigated the efficacy of therapeutic or standard prophylactic anticoagulation in...

Marco Torres | 24 de febrero de 2022

REBEL Core Cast 75.0 – Femoral Lines

Take Home Points: Newer data suggests that the infection and DVT rates for femoral lines are similar to that for internal jugular central lines. In a resuscitation situation, there are...

Marco Torres | 23 de febrero de 2022

Management of Digoxin Toxicity

A 78-year-old woman is brought in by EMS after her husband called 911 for increased confusion associated with intractable vomiting. On arrival to the emergency department (ED), the patient is...

Marco Torres | 21 de febrero de 2022

REBEL Cast Ep107: The BOUGIE Trial – Bougie First in All Emergency Intubations?

Background: Emergency endotracheal intubation is a potentially life-saving procedure in the management of critically-ill patients. The inherent risks associated with the procedure challenge us to refine our skills and adopt...

Marco Torres | 17 de febrero de 2022

The MICHELLE Trial: Anticoagulation Post-Discharge in Patients Hospitalized Secondary to COVID-19

Background: Patients diagnosed with COVID-19 have an increased risk of thromboembolic events, including pulmonary embolism and deep vein thrombosis (DVT). In addition, COVID-19 patients with increased coagulation parameters such as...

Marco Torres | 14 de febrero de 2022

REBEL Core Cast 74.0 – Cauda Equina Syndrome

Take Home Points: Cauda equina syndrome is a rare emergency with devastating consequences Early recognition is paramount as the presence of bladder dysfunction portends bad functional outcomes The presence of...

Marco Torres | 9 de febrero de 2022

REBEL Crit Cast Ep6.0 – Mastering Mechanical Ventilation Part 1

Mechanical Ventilation is a modality commonly used in the critically ill, but many providers, may not have a strong understanding of the basics. Emergency Medicine and Critical Care Physicians need...

Marco Torres | 31 de enero de 2022

The MOVe-Out Trial: Molnupiravir – Oral Antivirals for Management of Covid-19?

Background: On December 23, 2021, the FDA granted molnupiravir emergency use authorization for the treatment of patients with Covid-19. Molnupiravir is a nucleoside analog that inhibits SARS-CoV-2 replication and triggers...

Marco Torres | 27 de enero de 2022

REBEL Core Cast 73.0 – Basic Asthma Management

Take Home Points: First line treatment for asthma exacerbations is inhaled beta agonists, inhaled anticholinergics and systemic corticosteroids. The majority of patients presenting to the ED with asthma exacerbations should...

Marco Torres | 26 de enero de 2022

The Pragmatic Combination of YEARS Score and Age-Adjusted D-Dimer

Background: The optimal approach to risk stratifying patients for pulmonary embolism (PE) remains elusive. Multiple decision instruments are available with varying degrees of complexity and acceptance among emergency medicine clinicians...

Marco Torres | 24 de enero de 2022

The ACTIV-4b Trial: Antithrombotics For Treatment of Outpatient COVID-19

Background: Severely ill patients diagnosed with COVID-19 have an increased risk of cardiovascular complications, especially thromboembolic events (Bikdeli 2020). The overall incidence of developing venous thromboembolism (VTE) is approximately 17%...

Marco Torres | 20 de enero de 2022